133 related articles for article (PubMed ID: 34340930)
1. The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan.
Togano T; Uemura Y; Asai Y; Hayakawa K; Matsunaga N; Terada M; Ohtsu H; Suzuki S; Toyoda A; Hara H; Sato R; Ishikane M; Kinoshita-Iwamoto N; Hangaishi A; Ohmagari N
J Infect Chemother; 2021 Oct; 27(10):1498-1503. PubMed ID: 34340930
[TBL] [Abstract][Full Text] [Related]
2. Association between pre-admission anticoagulation and in-hospital death, venous thromboembolism, and major bleeding among hospitalized COVID-19 patients in Japan.
Adomi M; Kuno T; Komiyama J; Taniguchi Y; Abe T; Miyawaki A; Imai S; Morita K; Saito M; Ohbe H; Kamio T; Tamiya N; Iwagami M
Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):680-688. PubMed ID: 35324035
[TBL] [Abstract][Full Text] [Related]
3. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study.
Matli K; Chamoun N; Fares A; Zibara V; Al-Osta S; Nasrallah R; Salameh P; Mokhbat J; Ghanem G
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34611018
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan.
Hara H; Uemura Y; Hayakawa K; Togano T; Asai Y; Matsunaga N; Terada M; Ohtsu H; Kitajima K; Shimizu Y; Sato L; Ishikane M; Kinoshita-Iwamoto N; Shibata T; Kondo M; Izumi K; Sugiura W; Ohmagari N
Int J Infect Dis; 2021 Nov; 112():111-116. PubMed ID: 34517044
[TBL] [Abstract][Full Text] [Related]
5. Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19.
Corrochano M; Acosta-Isaac R; Mojal S; Miqueleiz S; Rodriguez D; Quijada-Manuitt MÁ; Fraga E; Castillo-Ocaña M; Amaro-Hosey K; Albiol N; Soria JM; Antonijoan RM; Souto JC
J Thromb Thrombolysis; 2022 Jan; 53(1):96-102. PubMed ID: 34138399
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study.
Chocron R; Galand V; Cellier J; Gendron N; Pommier T; Bory O; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Geneste L; Schmeltz A; Panagides V; Philippe A; Marsou W; Ben Abdallah I; Deney A; El Batti S; Attou S; Juvin P; Delmotte T; Messas E; Pezel T; Planquette B; Duceau B; Gaussem P; Sutter W; Sanchez O; Waldman V; Diehl JL; Mirault T; Bonnet G; Cohen A; Smadja DM;
J Am Heart Assoc; 2021 Apr; 10(8):e018624. PubMed ID: 33550816
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
8. The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study.
Nishimoto Y; Yachi S; Takeyama M; Tsujino I; Nakamura J; Yamamoto N; Nakata H; Ikeda S; Umetsu M; Aikawa S; Hayashi H; Satokawa H; Okuno Y; Iwata E; Ogihara Y; Ikeda N; Kondo A; Iwai T; Yamada N; Ogawa T; Kobayashi T; Mo M; Yamashita Y;
J Cardiol; 2022 Oct; 80(4):285-291. PubMed ID: 35430141
[TBL] [Abstract][Full Text] [Related]
9. Prior use of therapeutic anticoagulation does not protect against COVID-19 related clinical outcomes in hospitalized patients: A propensity score-matched cohort study.
Spiegelenberg JP; van Gelder MMHJ; Maas ML; Hovens MMC; Esselink A; Dofferhoff ASM; Janssen R; van de Maat J; Janssen N; Blaauw M; Hassing RJ; van Apeldoorn M; Kerckhoffs A; Veerman K; Hoogerwerf J; Kramers C; Leentjens J
Br J Clin Pharmacol; 2021 Dec; 87(12):4839-4847. PubMed ID: 33899226
[TBL] [Abstract][Full Text] [Related]
10. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients.
Parker K; Hamilton P; Hanumapura P; Castelino L; Murphy M; Challiner R; Thachil J; Ebah L
BMC Nephrol; 2021 Jun; 22(1):224. PubMed ID: 34134645
[TBL] [Abstract][Full Text] [Related]
11. The association of anticoagulation before admission and survival of patients with COVID-19.
Kuno T; Takahashi M; So M; Egorova NN
J Cardiol; 2022 Apr; 79(4):489-493. PubMed ID: 34974942
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study.
Russo V; Di Maio M; Attena E; Silverio A; Scudiero F; Celentani D; Lodigiani C; Di Micco P
Pharmacol Res; 2020 Sep; 159():104965. PubMed ID: 32474087
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan.
Terada M; Ohtsu H; Saito S; Hayakawa K; Tsuzuki S; Asai Y; Matsunaga N; Kutsuna S; Sugiura W; Ohmagari N
BMJ Open; 2021 Jun; 11(6):e047007. PubMed ID: 34130961
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of thromboembolic events and status of prophylactic anticoagulant therapy in hospitalized patients with COVID-19 in Japan.
Fujiwara S; Nakajima M; Kaszynski RH; Fukushima K; Tanaka M; Yajima K; Kobayashi T; Sekiya N; Yamamoto Y; Miwa M; Ishihata A; Yamauchi Y; Yamamoto K; Goto H; Imamura A
J Infect Chemother; 2021 Jun; 27(6):869-875. PubMed ID: 33663933
[TBL] [Abstract][Full Text] [Related]
15. The effect of anti-coagulation dosage on the outcome of hospitalized COVID-19 patients in Ethiopia: a multi-center retrospective cohort study.
Tessema AG; Mengiste ZM; Hundie TG; Yosef HG; Huluka DK; Seyoum AB; Abate HK; Howe RC
BMC Pulm Med; 2023 Mar; 23(1):85. PubMed ID: 36915064
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan.
Nomoto H; Suzuki S; Asai Y; Hayakawa K; Gatanaga H; Terada M; Suzuki K; Ohtsu H; Toyoda A; Ohmagari N
J Infect Chemother; 2022 Feb; 28(2):224-231. PubMed ID: 34776348
[TBL] [Abstract][Full Text] [Related]
18. Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities.
Rieder M; Gauchel N; Kaier K; Jakob C; Borgmann S; Classen AY; Schneider J; Eberwein L; Lablans M; Rüthrich M; Dolff S; Wille K; Haselberger M; Heuzeroth H; Bode C; von Zur Mühlen C; Rieg S; Duerschmied D
Clin Res Cardiol; 2022 Mar; 111(3):322-332. PubMed ID: 34546427
[TBL] [Abstract][Full Text] [Related]
19. Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID-19: A propensity score-matched analysis.
Chow JH; Yin Y; Yamane DP; Davison D; Keneally RJ; Hawkins K; Parr KG; Al-Mashat M; Berger JS; Bushardt RL; Mazzeffi MA; Nelson SJ
J Thromb Haemost; 2021 Nov; 19(11):2814-2824. PubMed ID: 34455688
[TBL] [Abstract][Full Text] [Related]
20. The impact of pre-injury anticoagulation therapy in the older adult patient experiencing a traumatic brain injury: A systematic review.
Smith K; Weeks S
JBI Libr Syst Rev; 2012; 10(58):4610-4621. PubMed ID: 27820526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
